Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Clinical trial NCT05460832 · COMPLETED

Trial details

NCT number: NCT05460832
Sponsor: Modern Biosciences Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2022-08-29
Primary completion: 2023-12-28
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.